What do dog owners want?

Back to normal

Success story: meet Karen

• Start once-daily dosing with Zenrelia to control pruritus.

• Within her first month of treatment, there was a notable decrease in the degree of pruritus.
• Karen’s itch levels returned to those observed in a normal dog.
• She was less irritable, both at home and at the recheck examination.

Success story: meet Maze

• Start once-daily Zenrelia to control pruritus.
• Use appropriate antibiotics, and medicated shampoos and creams.

• 11 days after beginning treatment, Maze’s pruritus had significantly decreased.
• The vet reported complete resolution of lesions on his abdomen and axillae; the lichenification was much improved.

Dosing made simple

Safety profile

Zenrelia has a safety profile comparable to Apoquel. ¹ It can be given alongside commonly used medications, including vaccines, antibiotics, parasiticides, ear cleaners, sedatives, anaesthetics and NSAIDs (non-steroidal anti-inflammatory drugs). ^{1, 4 †α} It is well-tolerated when given long-term for maintenance therapy. ^5‡

References

• ^††† 77% of dogs treated with Zenrelia achieved PVAS <2 by day 112 compared to 53% of dogs treated with Apoquel. A ‘normal’ itch score is considered to be comparable to that of a healthy, non-allergic dog (PVAS <2) ¹
• ^α Refer to SPC section 3.8 for more information.
• ^** Based on PVAS scores over first 14 days of treatment.¹
• ^‡ Based on Zenrelia use over a six-month period.
• ¹Forster S, Boegel A, et al. Veterinary Dermatology 2025;36:165–176
• ²Elanco Global Sales Data. June 2025.
• ³Rybnícek J et al. Vet Dermatol. 2009 Apr; 20(2):115-22.
• ⁴Zenrelia Summary of Product Characteristics.
• ⁵Kuntz EA et al. BMC Vet Res. 2025 Mar; 21:144.

Legals

Zenrelia™ film coated tablets contain ilunocitinib. Legal category POM-V in UK, POM in IE. For further information call Elanco Animal Health on +44(0)1256 353131 or write to: Elanco UK AH Limited, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA, United Kingdom. For further information, consult the product SPC. Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Apoquel® is a trademark of Zoetis UK Limited & Zoetis Belgium (IE).

©2025 Elanco or its affiliates PM-IE-25-0179 Date of preparation 09/25

Advice should be sought from the medicine prescriber prior to use. Prescription decisions are for the person issuing the prescription alone.

Use medicines responsibly www.noah.co.uk/responsible www.apha.ie